Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
NADc55hBNsKnxdfU
